cannabis indica

Índice completo — página 63 de 77

Estudos 6.201 a 6.300 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2012 a 2011. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 6.201 a 6.300

  1. 2012

    Nutritional n-3 polyunsaturated fatty acids deficiency alters cannabinoid receptor signaling pathway in the brain and associated anxiety-like behavior in mice

    FavorávelEstudo em AnimaisAnsiedadeOutros Compostos RelacionadosÔmega-3
  2. 2012

    Pain as a reward: changing the meaning of pain from negative to positive co-activates opioid and cannabinoid systems

  3. 2012

    Pain relief assessment by aromatic essential oil massage on outpatients with primary dysmenorrhea: a randomized, double-blind clinical trial.

    FavorávelEnsaio Clínico Duplo-CegoDistúrbios Menstruais
  4. 2012

    Palmitoylethanolamide in the treatment of chronic pain caused by different etiopathogenesis

    FavorávelEnsaio ClínicoDorDor — CrônicaDiabetesPalmitoiletanolamida (PEA)+5
  5. 2012

    Palmitoylethanolamide versus a nonsteroidal anti-inflammatory drug in the treatment of temporomandibular joint inflammatory pain

    FavorávelEnsaio ClínicoDorInflamaçãoArtritePalmitoiletanolamida (PEA)
  6. 2012

    Patient's perceptions of the cannabis-psychosis link--a systematic review

    DesfavorávelMetanálise ClínicaPsicoseEsquizofrenia
  7. 2012

    Patients with Asthma Benefit from Concomitant Therapy with Cineole: A Placebo-Controlled, Double-Blind Trial

    FavorávelEnsaio Clínico Duplo-CegoAsma
  8. 2012

    Perillyl Alcohol for the Treatment of Temozolomide-Resistant Gliomas

    FavorávelEstudo em AnimaisCâncerCâncer — Cérebro
  9. 2012

    Periodontal therapy decreases serum levels of adipocyte fatty acid-binding protein in systemically healthy subjects: a pilot clinical trial

  10. 2012

    Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions

  11. 2012

    Pharmacological interventions in the treatment of the acute effects of cannabis: a systematic review of literature

    FavorávelMetanálise ClínicaEfeitos Adversos da Cannabis
  12. 2012

    Phase II Trial on the Effects of Silexan in Patients With Neurasthenia, Post-Traumatic Stress Disorder or Somatization Disorder

    FavorávelEnsaio ClínicoAnsiedadeTEPT
  13. 2012

    Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour.

    FavorávelEstudo em AnimaisAnsiedadeTOCCanabigerol (CBG)Tetraidrocanabivarina (THCV)
  14. 2012

    Plasma phospholipid fatty acid concentration and incident coronary heart disease in men and women: the EPIC-Norfolk prospective study

  15. 2012

    Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of δ-9-tetrahydrocannabinol on midbrain and striatal function

    InconclusivoEnsaio ClínicoPsicoseEsquizofrenia
  16. 2012

    Prescribing Cannabis For Harm Reduction

    FavorávelMetanáliseDorDependência — OpioidesDor — Neuropatia Periférica
  17. 2012

    Progesterone-dependent Regulation of Endometrial Cannabinoid Receptor Type 1 (CB1-R) Expression is Disrupted in Women with Endometriosis and in Isolated Stromal Cells Exposed to TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin)

    InconclusivoEstudo LaboratorialEndometriose
  18. 2012

    Protective effects of alpha-pinene in mice with cerulein-induced acute pancreatitis

    FavorávelEstudo em AnimaisPancreatite
  19. 2012

    Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea

  20. 2012

    Regional changes in type 1 cannabinoid receptor availability in Parkinson's disease in vivo

    InconclusivoEnsaio ClínicoDoença de Parkinson
  21. 2012

    Renoprotective and antioxidant effects of cilnidipine in hypertensive patients

  22. 2012

    Revisiting CB1 receptor as drug target in human melanoma

  23. 2012

    Rimonabant improves obesity but not the overall cardiovascular risk and quality of life; results from CARDIO-REDUSE (CArdiometabolic Risk reDuctIOn by Rimonabant: the Effectiveness in Daily practice and its USE)

  24. 2012

    Role of arachidonoylethanolamine in blood pressure regulation in volume-resistant patients on peritoneal dialysis.

  25. 2012

    Role of cannabinoids in the regulation of bone remodeling

    FavorávelMetanáliseOsteoporoseEndocanabinoide (não especificado)
  26. 2012

    Role of the endocannabinoid system in extinction of fear memories: lessons from animal studies

  27. 2012

    Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis

    FavorávelEnsaio ClínicoPsicoseEsclerose MúltiplaTHC:CBD Farmacêutico
  28. 2012

    Sativex-like Combination of Phytocannabinoids is Neuroprotective in Malonate-Lesioned Rats, an Inflammatory Model of Huntington’s Disease: Role of CB1 and CB2 Receptors.

  29. 2012

    Single-dose Pharmacokinetics and Tolerability of Oral Delta-9- Tetrahydrocannabinol in Patients with Amyotrophic Lateral Sclerosis

    DesfavorávelEnsaio ClínicoDoenças Neurodegenerativas
  30. 2012

    Smoked Cannabis for Spasticity in Multiple Sclerosis: A Randomized, Placebo-Controlled Trial

    FavorávelEnsaio Clínico Duplo-CegoEsclerose MúltiplaDistonia
  31. 2012

    Spice, bath salts, and the U.S. military: the emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. Armed Forces

  32. 2012

    Stress-induced sensitization of cortical adrenergic receptors following a history of cannabinoid exposure

    FavorávelEstudo em AnimaisCanabinoides Sintéticos WIN-x
  33. 2012

    Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis.

    FavorávelEstudo em AnimaisEsclerose Sistêmica
  34. 2012

    Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities.

  35. 2012

    Terpinolene, a component of herbal sage, downregulates AKT1 expression in K562 cells.

    FavorávelEstudo LaboratorialCâncer
  36. 2012

    The cannabinoid CB1 receptor antagonists rimonabant (SR141716) and AM251 directly potentiate GABA(A) receptors

  37. 2012

    The CB₁ receptor-mediated endocannabinoid signaling and NGF: the novel targets of curcumin

    FavorávelEstudo em AnimaisDepressãoCanabinoides Sintéticos AM-xCanabinoides Sintéticos SR-x+1
  38. 2012

    The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects

    FavorávelEstudo em AnimaisDorInflamaçãoDor — CrônicaCanabinoides Sintéticos O-x+2
  39. 2012

    The effect of camphor and borneol on rat thymocyte viability and oxidative stress

    FavorávelEstudo LaboratorialInflamação
  40. 2012

    The effects of multitasking on psychological stress reactivity in recreational users of cannabis and MDMA

    DesfavorávelMetanáliseEfeitos Adversos da CannabisEfeitos Adversos do MDMA
  41. 2012

    The endocannabinoid N-arachidonoyl dopamine (NADA) selectively induces oxidative stress-mediated cell death in hepatic stellate cells but not in hepatocytes

    FavorávelEstudo LaboratorialFibroseFibrose — Hepática (Cirrose)N-Araquidonoil Dopamina (NADA)
  42. 2012

    The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity

  43. 2012

    The Endocannabinoid System In Normal And Pathological Brain Aging

  44. 2012

    The endocannabinoids anandamide and virodhamine modulate the activity of the candidate cannabinoid receptor GPR55

    FavorávelEstudo LaboratorialInflamaçãoVirodamina (O-AEA)
  45. 2012

    The l-α-Lysophosphatidylinositol/GPR55 System and Its Potential Role in Human Obesity

  46. 2012

    The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications

  47. 2012

    The role of the endocannabinoid system in eating disorders: pharmacological implications

    FavorávelMetanáliseAnorexia (perda de apetite)CaquexiaAnorexia Nervosa
  48. 2012

    The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity

  49. 2012

    Topical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice

    FavorávelEstudo em AnimaisDII — Doença Inflamatória IntestinalHemorroidas
  50. 2012

    Total intermittent Pringle maneuver during liver resection can induce intestinal epithelial cell damage and endotoxemia

  51. 2012

    Toxic effects of marijuana on the cardiovascular system

  52. 2012

    Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease

  53. 2012

    Unbalance of CB1 receptors expressed in GABAergic and glutamatergic neurons in a transgenic mouse model of Huntington's disease.

    FavorávelEstudo em AnimaisDoença de HuntingtonCanabinoides Sintéticos WIN-x
  54. 2012

    Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome.

  55. 2012

    Would some cannabinoids ameliorate symptoms of autism?

    FavorávelMetanáliseAutismoTetraidrocanabinol (THC)
  56. 2012

    α-Terpineol Reduces Mechanical Hypernociception and Inflammatory Response

    FavorávelEstudo em AnimaisDorInflamação
  57. 2012

    Δ8-Tetrahydrocannabivarin Prevents Hepatic Ischaemia/Reperfusion Injury by Decreasing Oxidative Stress and Inflammatory Responses Through Cannabinoid CB2 Receptors

  58. 2012

    Δ9-Tetrahydrocannabinol (Δ9-THC) attenuates mouse sperm motility and male fecundity

    DesfavorávelEstudo em AnimaisInfertilidade MasculinaCanabinoides Sintéticos WIN-x
  59. 2012

    Δ⁹-tetrahydrocannabinol (Δ⁹-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease.

  60. 2012

    Δ9-Tetrahydrocannabinol attenuates MDMA-induced hyperthermia in rhesus monkeys

  61. 2011

    A Combined Preclinical Therapy Of Cannabinoids And Temozolomide Against Glioma

  62. 2011

    A novel mechanism for acupuncture-induced analgesia: involvement of orexins and endocannabinoids

    FavorávelEstudo em AnimaisDorDor — Crônica2-Araquidonoilglicerol (2-AG)Acupuntura (MTC)
  63. 2011

    A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols)

  64. 2011

    A randomized, double-blind, placebo-controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis use

  65. 2011

    A systematic meta-review grading the evidence for non-genetic risk factors and putative antecedents of schizophrenia

    DesfavorávelMetanálise ClínicaEsquizofreniaTetraidrocanabinol (THC)
  66. 2011

    Activation of spinal and supraspinal cannabinoid-1 receptors lead to antinociception in a rat model of neuropathic spinal cord injury pain

  67. 2011

    Activity of Melaleuca Alternifolia (Tea Tree) Oil on Influenza Virus A/PR/8: Study on the Mechanism of Action

    FavorávelEstudo LaboratorialGripe
  68. 2011

    Acute effects of a selective cannabinoid-2 receptor agonist on neuroinflammation in a model of traumatic brain injury

    FavorávelEstudo em AnimaisAVCTraumatismo CranioencefálicoCanabinoides Sintéticos O-x
  69. 2011

    Addition of aliskiren to olmesartan ameliorates tubular injury in chronic kidney disease patients partly by reducing proteinuria

  70. 2011

    Adipose tissue endocannabinoid system gene expression: depot differences and effects of diet and exercise

  71. 2011

    Administration of 2-arachidonoylglycerol ameliorates both acute and chronic experimental autoimmune encephalomyelitis

    FavorávelEstudo em AnimaisEncefalite e Mielite2-Araquidonoilglicerol (2-AG)
  72. 2011

    Alkamides and a neolignan from Echinacea purpurea roots and the interaction of alkamides with G-protein-coupled cannabinoid receptors

    FavorávelEstudo LaboratorialEquinácea
  73. 2011

    Allergic hypersensitivity to cannabis in patients with allergy and illicit drug users

    DesfavorávelMetanáliseAlergia à Cannabis
  74. 2011

    Alterations in Corticolimbic Dendritic Morphology and Emotional Behavior in Cannabinoid CB1 Receptor–Deficient Mice Parallel the Effects of Chronic Stress.

    FavorávelEstudo em AnimaisAnsiedadeDepressão
  75. 2011

    An overview of the metabolic effects of rimonabant in randomized controlled trials: potential for other cannabinoid 1 receptor blockers in obesity

    InconclusivoMetanálise ClínicaObesidadeCanabinoide Sintético (não especificado)
  76. 2011

    Anandamide capacitates bull spermatozoa through CB1 and TRPV1 activation

    FavorávelEstudo LaboratorialAplicações VeterináriasInfertilidade MasculinaAnandamida (AEA)
  77. 2011

    Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor

    FavorávelEstudo em AnimaisCâncerCâncer — FígadoAnandamida (AEA)
  78. 2011

    ANKK1/DRD2 locus variants are associated with rimonabant efficacy in aiding smoking cessation: pilot data

  79. 2011

    Antagonist-elicited cannabis withdrawal in humans

  80. 2011

    Anti-emetic drugs in oncology: pharmacology and individualization by pharmacogenetics.

  81. 2011

    Anti-scratching Behavioral Effect of the Essential Oil and Phytol Isolated From Artemisia Princeps Pamp. In Mice

    FavorávelEstudo em AnimaisDermatite de Contato Alérgica
  82. 2011

    Anti-tumoral Action Of Cannabinoids On Hepatocellular Carcinoma: Role Of AMPK-dependent Activation Of Autophagy

  83. 2011

    Antioxidative Effects of Curcumin, β-Myrcene and 1,8-cineole Against 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced Oxidative Stress in Rats Liver

    FavorávelEstudo em AnimaisEstresse OxidativoInsuficiência Hepática
  84. 2011

    Antiproliferative mechanism of a cannabinoid agonist by cell cycle arrest in human gastric cancer cells

    FavorávelEstudo LaboratorialCâncerCâncer — EstômagoCanabinoides Sintéticos WIN-x
  85. 2011

    Antitumor effects of α-bisabolol against pancreatic cancer

    FavorávelEstudo em AnimaisCâncerCâncer — Pâncreas
  86. 2011

    Artemisia princeps Pamp. Essential Oil and Its Constituents Eucalyptol and α-terpineol Ameliorate Bacterial Vaginosis and Vulvovaginal Candidiasis in Mice by Inhibiting Bacterial Growth and NF-κB Activation

    FavorávelEstudo em AnimaisInflamaçãoInfecções BacterianasInfecções Fúngicas
  87. 2011

    Assessment of Hospice Health Professionals' Knowledge, Views, and Experience With Medical Marijuana

    FavorávelMetanáliseCuidados Paliativos
  88. 2011

    Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential

  89. 2011

    Association Study of Two Cannabinoid Receptor Genes, CNR1 and CNR2, with Methamphetamine Dependence

    InconclusivoMetanáliseDependência QuímicaPsicoseEsquizofrenia+1
  90. 2011

    b-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation.

    FavorávelEstudo LaboratorialCâncerCâncer — MamaCâncer — Próstata
  91. 2011

    Behavioral effects of fatty acid amide hydrolase inhibition on morphine withdrawal symptoms

  92. 2011

    Biomarkers for early detection of sickle nephropathy

  93. 2011

    Borneol alleviates oxidative stress via upregulation of Nrf2 and Bcl-2 in SH-SY5Y cells

    FavorávelEstudo LaboratorialEstresse OxidativoDoença de Alzheimer
  94. 2011

    Brain Cannabinoid CB₂ Receptors Modulate Cocaine's Actions In Mice

    FavorávelEstudo em AnimaisDependência QuímicaDependência — Cocaína
  95. 2011

    Brain type 1 cannabinoid receptor availability in patients with anorexia and bulimia nervosa

    InconclusivoMetanáliseAnorexia (perda de apetite)Anorexia Nervosa
  96. 2011

    Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study

  97. 2011

    Camphene, a Plant-Derived Monoterpene, Reduces Plasma Cholesterol and Triglycerides in Hyperlipidemic Rats Independently of HMG-CoA Reductase Activity.

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Aterosclerose
  98. 2011

    Cannabidiol as an Emergent Therapeutic Strategy for Lessening the Impact of Inflammation on Oxidative Stress.

  99. 2011

    Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice

    FavorávelEstudo em AnimaisInsuficiência Hepática
  100. 2011

    Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice

    FavorávelEstudo em AnimaisEsclerose MúltiplaTuberculose